(XHS) SPDR S&P Health Care - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US78464A5737 • Health
XHS: Hospitals, Medical, Facilities, Laboratories, Insurance, Pharmaceuticals
The SPDR® S&P Health Care Services ETF (NYSE ARCA:XHS) is designed to provide exposure to the health care services sector by tracking the performance of the S&P Health Care Services Select Industry Index. The fund employs a sampling strategy, typically investing at least 80% of its total assets in securities that comprise the index. This approach allows for efficient tracking of the indexs performance while maintaining liquidity. The index itself is a subset of the S&P Total Market Index (S&P TMI), focusing specifically on companies within the health care services segment. This includes entities involved in health care equipment, services, and distributors. For more information, visit: http://www.spdrs.com.
As an ETF, XHS offers investors a targeted way to gain exposure to the health care services industry. Its investment strategy involves replicating the holdings and weightings of the S&P Health Care Services Select Industry Index, ensuring that the funds portfolio aligns closely with the indexs composition. The funds assets under management (AUM) total $82.56 million, indicating a moderate size that balances accessibility with diversification. This structure allows XHS to serve as a tool for investors seeking to capitalize on the growth and stability of the health care services sector within the broader market.
Additional Sources for XHS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
XHS ETF Overview
Market Cap in USD | 84m |
Category | Health |
TER | 0.35% |
IPO / Inception | 2011-09-28 |
XHS ETF Ratings
Growth 5y | 41.9% |
Fundamental | - |
Dividend | 43.7% |
Rel. Strength Industry | -5 |
Analysts | - |
Fair Price Momentum | 86.77 USD |
Fair Price DCF | - |
XHS Dividends
Dividend Yield 12m | 0.36% |
Yield on Cost 5y | 0.67% |
Annual Growth 5y | 8.64% |
Payout Consistency | 73.2% |
XHS Growth Ratios
Growth Correlation 3m | 54% |
Growth Correlation 12m | 65.7% |
Growth Correlation 5y | 9.9% |
CAGR 5y | 13.21% |
CAGR/Max DD 5y | 0.41 |
Sharpe Ratio 12m | 0.48 |
Alpha | -4.00 |
Beta | 0.65 |
Volatility | 21.16% |
Current Volume | 2.2k |
Average Volume 20d | 6.2k |
As of March 14, 2025, the stock is trading at USD 93.56 with a total of 2,247 shares traded.
Over the past week, the price has changed by -3.16%, over one month by -7.68%, over three months by -0.68% and over the past year by +2.83%.
Partly, yes. Based on ValueRay Analyses, SPDR S&P Health Care (NYSE ARCA:XHS) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 41.85 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XHS as of March 2025 is 86.77. This means that XHS is currently overvalued and has a potential downside of -7.26%.
SPDR S&P Health Care has no consensus analysts rating.
According to ValueRays Forecast Model, XHS SPDR S&P Health Care will be worth about 96.2 in March 2026. The stock is currently trading at 93.56. This means that the stock has a potential upside of +2.82%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 96.2 | 2.8% |